A randomized clinical trial of trans-dermal nicotine replacement in pregnant African-American smokers

Ayman A E El-Mohandes, Richard Windsor, Sylvia Tan, David C Perry, Marie G Gantz, Michele Kiely, Ayman A E El-Mohandes, Richard Windsor, Sylvia Tan, David C Perry, Marie G Gantz, Michele Kiely

Abstract

We compared acceptability, adherence and efficacy of trans-dermal nicotine patches and cognitive behavioral therapy (Group 1) to cognitive behavioral therapy alone (Group 2) in minority pregnant smokers. This is a randomized controlled trial. 52 women were recruited during pregnancy with a mean gestational age 18.5 ± 5.0 weeks and followed through delivery. Randomization was by site and initial cotinine levels. Interventionists and interviewers were blinded to group assignment. Two different nicotine replacement therapy dosing regiments were administered according to the baseline salivary cotinine level. A process evaluation model summarized patient adherence. The main outcome measure was self-report of cessation since last visit, confirmed by exhaled carbon monoxide. Analyses of categorical and continuous measures were conducted as well as linear trend tests of salivary cotinine levels. Women lost to follow-up were considered treatment failures. Participants were on average 27.5 ± 5.4 years old, 81 % were single, 69 % unemployed and 96 % were Medicaid eligible. A process evaluation indicated patients in both groups were adherent to scheduled program procedures through Visit 4, but not for Visits 5 and 6. Confirmed quit rates were: at visit 3, 23 (Group 1) and 0 % (Group 2) (p = 0.02); at visits 4 and 5, no difference; at visit 6, 19 (Group 1) and 0 % (Group 2) (p = 0.05). Group 1 delivered infants with a mean gestational age of 39.4 weeks versus 38.4 weeks in Group 2 (p = 0.02). 73 % (52/71) of the eligible smokers agreed to participate and 65 % (17/26) of Group 1 completed the protocol (i.e. attended 6 visits). A comparison of Group 1 and 2 quit rates confirmed a non-significant difference.

Trial registration: ClinicalTrials.gov NCT00341432.

Figures

Fig. 1
Fig. 1
NRT study flowchart. §Met sociodemographic, pregnancy, and gestational age criteria, reported smoking during pregnancy, and wanted to quit. *Two women were each screened and randomized into the study twice. Each pregnancy was counted as a separate study participation. ΩOne participant was randomized to NRT, but was subsequently admitted into a rehabilitation facility and was discontinued. She was never administered NRT. Neither woman quit smoking at any time during the pregnancy
Fig. 2
Fig. 2
Mean cotinine level by care group

Source: PubMed

3
Subscribe